Hypoxia, innate immunity and infection in the lung

Respiratory Physiology and Neurobiology

Volumn 174, Issue 3, 2010, Pages 235-243

  Schaible, Bettina ^a   Schaffer, Kirsten ^b   Taylor, Cormac T ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Hypoxia; Inflammation; Innate immunity; Lung; Pulmonary disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHEMOKINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TOLL LIKE RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL VIRULENCE; BONE MARROW CELL; CYSTIC FIBROSIS; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; HYPOXIA; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANOXIA; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LUNG; LUNG DISEASES; OXYGEN; SIGNAL TRANSDUCTION;

EID: 78449276907     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.08.006     Document Type: Review

References (78)

1. Acosta-Iborra B., Elorza A., Olazabal I.M., Martin-Cofreces N.B., Martin-Puig S., Miro M., Calzada M.J., Aragones J., Sanchez-Madrid F., Landazuri M.O. Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J. Immunol. 2009, 182:3155-3164.
2. Adamo R., Sokol S., Soong G., Gomez M.I., Prince A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am. J. Respir. Cell Mol. Biol. 2004, 30:627-634.
3. Ayieko P., English M. In children aged 2-59 months with pneumonia, which clinical signs best predict hypoxaemia?. J. Trop. Pediatr. 2006, 52:307-310.
4. Barbier M., Agusti A., Alberti S. Fluticasone propionate reduces bacterial airway epithelial invasion. Eur. Respir. J. 2008, 32:1283-1288.
5. Bartlett J.A., Fischer A.J., McCray P.B. Innate immune functions of the airway epithelium. Contrib. Microbiol. 2008, 15:147-163.
6. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
7. Chao J., Wood J.G., Blanco V.G., Gonzalez N.C. The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s). Am. J. Respir. Cell Mol. Biol. 2009, 41:573-582.
8. Chaudhuri N., Sabroe I. Basic science of the innate immune system and the lung. Paediatr. Respir. Rev. 2008, 9:236-242.
9. Chilvers M.A., O'Callaghan C. Local mucociliary defence mechanisms. Paediatr. Respir. Rev. 2000, 1:27-34.
10. Chun C.D., Liu O.W., Madhani H.D. A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog. 2007, 3:e22.
11. Clerici C., Planes C. Gene regulation in the adaptive process to hypoxia in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L267-274.
12. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.P., Ferrara N., Johnson R.S. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657.
13. Cramton S.E., Ulrich M., Gotz F., Doring G. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 2001, 69:4079-4085.
14. Cummins E.P., Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch. 2005, 450:363-371.
15. Cummins E.P., Berra E., Comerford K.M., Ginouves A., Fitzgerald K.T., Seeballuck F., Godson C., Nielsen J.E., Moynagh P., Pouyssegur J., Taylor C.T. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18154-18159.
16. de Beer D., Stoodley P., Lewandowski Z. Measurement of local diffusion coefficients in biofilms by microinjection and confocal microscopy. Biotechnol. Bioeng. 1997, 53:151-158.
17. Edwards M.R., Bartlett N.W., Clarke D., Birrell M., Belvisi M., Johnston S.L. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol. Ther. 2009, 121:1-13.
18. Ganz T. Antimicrobial polypeptides. J. Leukoc. Biol. 2004, 75:34-38.
19. Geijtenbeek T.B., Gringhuis S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009, 9:465-479.
20. Gomez M.I., Prince A. Airway epithelial cell signaling in response to bacterial pathogens. Pediatr. Pulmonol. 2008, 43:11-19.
21. Gonzalez N.C., Allen J., Blanco V.G., Schmidt E.J., van Rooijen N., Wood J.G. Alveolar macrophages are necessary for the systemic inflammation of acute alveolar hypoxia. J. Appl. Physiol. 2007, 103:1386-1394.
22. Greene C.M., Carroll T.P., Smith S.G., Taggart C.C., Devaney J., Griffin S., O'Neill S.J., McElvaney N.G. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 2005, 174:1638-1646.
23. Gribar S.C., Richardson W.M., Sodhi C.P., Hackam D.J. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol. Med. 2008, 14:645-659.
24. Guimbellot J.S., Fortenberry J.A., Siegal G.P., Moore B., Wen H., Venglarik C., Chen Y.F., Oparil S., Sorscher E.J., Hong J.S. Role of oxygen availability in CFTR expression and function. Am. J. Respir. Cell Mol. Biol. 2008, 39:514-521.
25. Hall-Stoodley L., Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009, 11:1034-1043.
26. Hansel T.T., Barnes P.J. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet 2009, 374:744-755.
27. Hassett D.J. Anaerobic production of alginate by Pseudomonas aeruginosa: alginate restricts diffusion of oxygen. J. Bacteriol. 1996, 178:7322-7325.
28. Hill D., Rose B., Pajkos A., Robinson M., Bye P., Bell S., Elkins M., Thompson B., Macleod C., Aaron S.D., Harbour C. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J. Clin. Microbiol. 2005, 43:5085-5090.
29. Hong C.S., Shitashiro M., Kuroda A., Ikeda T., Takiguchi N., Ohtake H., Kato J. Chemotaxis proteins and transducers for aerotaxis in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2004, 231:247-252.
30. Jacquot J., Tabary O., Le Rouzic P., Clement A. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int. J. Biochem. Cell Biol. 2008, 40:1703-1715.
31. Jain M., Sznajder J.I. Effects of hypoxia on the alveolar epithelium. Proc. Am. Thorac. Soc. 2005, 2:202-205.
32. Jantsch J., Chakravortty D., Turza N., Prechtel A.T., Buchholz B., Gerlach R.G., Volke M., Glasner J., Warnecke C., Wiesener M.S., Eckardt K.U., Steinkasserer A., Hensel M., Willam C. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J. Immunol. 2008, 180:4697-4705.
33. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
34. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
35. Keely S., Glover L.E., Weissmueller T., MacManus C.F., Fillon S., Fennimore B., Colgan S.P. Hypoxia-inducible factor-dependent regulation of platelet-activating factor receptor as a route for Gram-positive bacterial translocation across epithelia. Mol. Biol. Cell 2010, 21:538-546.
36. Kim S.Y., Choi Y.J., Joung S.M., Lee B.H., Jung Y.S., Lee J.Y. Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 2010, 129:516-524.
37. Kohler J.E., Zaborina O., Wu L., Wang Y., Bethel C., Chen Y., Shapiro J., Turner J.R., Alverdy J.C. Components of intestinal epithelial hypoxia activate the virulence circuitry of Pseudomonas. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G1048-1054.
38. Kuhlicke J., Frick J.S., Morote-Garcia J.C., Rosenberger P., Eltzschig H.K. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One 2007, 2:e1364.
39. Leid J.G., Willson C.J., Shirtliff M.E., Hassett D.J., Parsek M.R., Jeffers A.K. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 2005, 175:7512-7518.
40. Leonard M.O., Howell K., Madden S.F., Costello C.M., Higgins D.G., Taylor C.T., McLoughlin P. Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung. Am. J. Respir. Crit. Care Med. 2008, 178:977-983.
41. Li Q.F., Wang X.R., Yang Y.W., Lin H. Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell Res. 2006, 16:548-558.
42. Maderna P., Godson C. Lipoxins: resolutionary road. Br. J. Pharmacol. 2009, 158:947-959.
43. Mahenthiralingam E., Campbell M.E., Speert D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 1994, 62:596-605.
44. Martinez-Garcia M.A., Soler-Cataluna J.J., Perpina-Tordera M., Roman-Sanchez P., Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007, 132:1565-1572.
45. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2001, 2:599-609.
46. McNicholas W.T. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am. J. Respir. Crit. Care Med. 2009, 180:692-700.
47. Mogayzel P.J., Flume P.A. Update in cystic fibrosis 2009. Am. J. Respir. Crit. Care Med. 2010, 181:539-544.
48. Muir A., Soong G., Sokol S., Reddy B., Gomez M.I., Van Heeckeren A., Prince A. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 2004, 30:777-783.
49. Nichols D., Chmiel J., Berger M. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin. Rev. Allergy Immunol. 2008, 34:146-162.
50. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., Johnson R.S. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 2005, 115:1806-1815.
51. Peyssonnaux C., Cejudo-Martin P., Doedens A., Zinkernagel A.S., Johnson R.S., Nizet V. Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis. J. Immunol. 2007, 178:7516-7519.
52. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., Johnson R.S., Haddad G.G., Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
53. Rustad T.R., Sherrid A.M., Minch K.J., Sherman D.R. Hypoxia: a window into mycobacterium tuberculosis latency. Cell Microbiol. 2009, 11:1151-1159.
54. Sanz F., Restrepo M.I., Fernandez E., Briones M.L., Blanquer R., Mortensen E.M., Chiner E., Blanquer J. Is it possible to predict which patients with mild pneumonias will develop hypoxemia?. Respir. Med. 2009, 103:1871-1877.
55. Semenza G.L. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir. Res. 2000, 1:159-162.
56. Semenza G.L. Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology. Chest 2005, 128:592S-594S.
57. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, 2007. cm8.
58. Signorelli S., Jennings P., Leonard M.O., Pfaller W. Differential effects of hypoxic stress in alveolar epithelial cells and microvascular endothelial cells. Cell. Physiol. Biochem. 2010, 25:135-144.
59. Singh P.K., Schaefer A.L., Parsek M.R., Moninger T.O., Welsh M.J., Greenberg E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764.
60. Spilker T., Coenye T., Vandamme P., LiPuma J.J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J. Clin. Microbiol. 2004, 42:2074-2079.
61. Sumbayev V.V. LPS-induced Toll-like receptor 4 signalling triggers cross-talk of apoptosis signal-regulating kinase 1 (ASK1) and HIF-1alpha protein. FEBS Lett. 2008, 582:319-326.
62. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
63. Taylor C.T. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol. 2008, 586:4055-4059.
64. Taylor C.T. Mitochondria and cellular oxygen sensing in the HIF pathway. Biochem. J. 2008, 409:19-26.
65. Thomas E.L., Lehrer R.I., Rest R.F. Human neutrophil antimicrobial activity. Rev. Infect. Dis. 1988, 10(Suppl. 2):S450-456.
66. Tuder R.M., Yun J.H., Bhunia A., Fijalkowska I. Hypoxia and chronic lung disease. J. Mol. Med. 2007, 85:1317-1324.
67. Urquhart D.S., Montgomery H., Jaffe A. Assessment of hypoxia in children with cystic fibrosis. Arch. Dis. Child. 2005, 90:1138-1143.
68. Via L.E., Lin P.L., Ray S.M., Carrillo J., Allen S.S., Eum S.Y., Taylor K., Klein E., Manjunatha U., Gonzales J., Lee E.G., Park S.K., Raleigh J.A., Cho S.N., McMurray D.N., Flynn J.L., Barry C.E. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 2008, 76:2333-2340.
69. von Garnier C., Nicod L.P. Immunology taught by lung dendritic cells. Swiss Med. Wkly. 2009, 139:186-192.
70. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., Sobolewski A., Condliffe A.M., Cowburn A.S., Johnson N., Chilvers E.R. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J. Exp. Med. 2005, 201:105-115.
71. Walmsley S.R., Cowburn A.S., Clatworthy M.R., Morrell N.W., Roper E.C., Singleton V., Maxwell P., Whyte M.K., Chilvers E.R. Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis. Blood 2006, 108:3176-3178.
72. Willger S.D., Puttikamonkul S., Kim K.H., Burritt J.B., Grahl N., Metzler L.J., Barbuch R., Bard M., Lawrence C.B., Cramer R.A. A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog. 2008, 4:e1000200.
73. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Doring G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 2002, 109:317-325.
74. Wyckoff T.J., Thomas B., Hassett D.J., Wozniak D.J. Static growth of mucoid Pseudomonas aeruginosa selects for non-mucoid variants that have acquired flagellum-dependent motility. Microbiology 2002, 148:3423-3430.
75. Yoon S.S., Hennigan R.F., Hilliard G.M., Ochsner U.A., Parvatiyar K., Kamani M.C., Allen H.L., DeKievit T.R., Gardner P.R., Schwab U., Rowe J.J., Iglewski B.H., McDermott T.R., Mason R.P., Wozniak D.J., Hancock R.E., Parsek M.R., Noah T.L., Boucher R.C., Hassett D.J. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 2002, 3:593-603.
76. Zheng W., Kuhlicke J., Jackel K., Eltzschig H.K., Singh A., Sjoblom M., Riederer B., Weinhold C., Seidler U., Colgan S.P., Karhausen J. Hypoxia inducible factor-1 (HIF-1)-mediated repression of cystic fibrosis transmembrane conductance regulator (CFTR) in the intestinal epithelium. FASEB J. 2009, 23:204-213.
77. Zhou G., Dada L.A., Sznajder J.I. Regulation of alveolar epithelial function by hypoxia. Eur. Respir. J. 2008, 31:1107-1113.
78. Zinkernagel A.S., Johnson R.S., Nizet V. Hypoxia inducible factor (HIF) function in innate immunity and infection. J. Mol. Med. 2007, 85:1339-1346.